The vascular endothelial growth factor receptors (VEGFRs, 1-3), platelet-derived growth factor receptors (PDGFRs, α and β), and c-Kit pathways are among the most commonly dysregulated in soft tissue sarcomas (8). Here, KIT is linked to soft tissue sarcoma.